As India’s population surges, affordable healthcare has become very important.  Pharmaceutical, medical devices and life sciences companies are broadening their footprint in the Indian market and are also increasing their R&D investments in India.  On the other hand, the Indian government has brought in price control regulations to cap the pricing of expensive drugs and medical devices, due to which the legal challenges faced by clients in this industry are many.

With its in-depth knowledge of the regulatory nuances in this industry sector and expertise in Indian drugs, IP, licensing and related laws, Majmudar & Partners guides its clients and assists them in overcoming these issues in a smooth and efficient manner.

We have significant experience in licensing transactions, IP protection, medical device disputes, patent filings and pharma-regulatory work, apart from complex trademark infringement and passing off cases.  In addition, our corporate team advises companies on foreign exchange regulatory, tax, employment and antitrust matters, and M&A transactions.  Our clients include multinational pharmaceutical companies, hospitals, health insurance companies, medical devices companies, and medical organizations.